When was Adial Pharmaceuticals, Inc. stock made available for the first time to the public?

The IPO Date for Adial Pharmaceuticals, Inc. is 2018-07-27. On this 2018-07-27, Adial Pharmaceuticals, Inc. stock was made publicly available.

Where is the headquarters of Adial Pharmaceuticals, Inc. stock?

Headquarters of Adial Pharmaceuticals, Inc. is in US at 1180 Seminole Trail, Charlottesville, VA 22901.

What industry does Adial Pharmaceuticals, Inc. belong to?

The Adial Pharmaceuticals, Inc. belongs to Biotechnology.

Adial Pharmaceuticals, Inc.

ADIL•NASDAQ

Healthcare

Biotechnology

$0.47

$0.22(90.98%)

Adial Pharmaceuticals, Inc. (ADIL) Company Profile & Overview

Explore Adial Pharmaceuticals, Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Adial Pharmaceuticals, Inc. (ADIL) Company Profile & Overview

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a selective serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

SectorHealthcare

IndustryBiotechnology

CEOMr. Cary John Claiborne MBA

Contact Information

https://www.adialpharma.com

434 422 9800

1180 Seminole Trail, Charlottesville, VA, 22901

Company Facts

5 Employees

IPO DateJul 27, 2018

CountryUS

Actively Trading

Frequently Asked Questions

;